Neuroblastoma Pathology

Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification

“…As indicated above and also detailed in our article, 25 we are gaining additional insight into the potential molecular targets that underlie the therapy-resistant and aggressive behavior of UH neuroblastomas. Moreover, therapy resistance is often attributed to a protein functional level but it is difficult to defeat it because of the inherent plasticity/stemness of tumor cells.…”